Perry Ellis International Names David Rattner as Chief

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
210
Perry Ellis International Names David Rattner as Chief Financial Officer

MIAMI, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Perry Ellis International, Inc. (NASDAQ: PERY ) announced today the appointment of David Rattner as Chief Financial Officer of Perry Ellis International, Inc., reporting to Oscar Feldenkreis, CEO & President of Perry Ellis International. David brings over 20 years of financial experience from Elizabeth Arden, most recently serving as VP Finance and Corporate Controller. Anita Britt announced her retirement from the company effective March 31, 2017 and will ensure the transition of the CFO office is seamless.

“We are pleased to welcome David to Perry Ellis International and expect his breadth of experience will be a critical element as we enter the growth mode of our 5 point growth and profitability plan,” commented Oscar Feldenkreis. “We thank Anita for her eight years of contributions at Perry Ellis.  She has been instrumental in assisting Perry Ellis to drive gross margin expansion, expense savings and inventory turns.  Anita has built a solid finance team and with her help we anticipate a smooth transition over the next few months.”

Anita Britt stated, “I am proud of my time at Perry Ellis and feel fortunate to have worked with George and Oscar Feldenkreis and the entire organization.  Perry Ellis is a unique company with powerful brands and a strong operating platform.  I look forward to supporting David in his new role and to ensure a smooth transition.”

“I am thrilled to join the talented Perry Ellis team and believe the potential for growth and value creation is tremendous,” said Mr. Rattner.  “These are both exciting and challenging times in the apparel industry, which present real opportunities for a company like Perry Ellis , with its strong portfolio of brands and its focus on delivering innovative retail experience to its customers and consumers."

Mr. Rattner holds a B.S. in accounting from the University of Florida and is a certified public accountant.

For more information about Perry Ellis International, Inc. and the company’s entire portfolio of brands, please visit  www.PERY.com .

About Perry Ellis International

Perry Ellis International, Inc. is a leading designer, distributor and licensor of a broad line of high quality men's and women's apparel, accessories and fragrances. The Company's collection of dress and casual shirts, golf sportswear, sweaters, dress pants, casual pants and shorts, jeans wear, active wear, dresses and men's and women's swimwear is available through all major levels of retail distribution. The Company, through its wholly owned subsidiaries, owns a portfolio of nationally and internationally recognized brands, including: Perry Ellis®, Original Penguin® by Munsingwear®, Laundry by Shelli Segal®, Rafaella®, Cubavera®, Ben Hogan®, Savane®, Grand Slam®, John Henry®, Manhattan®, Axist®, Jantzen® and Farah®.  The Company enhances its roster of brands by licensing trademarks from third parties, including: Nike® and Jag® for swimwear, and Callaway®, PGA TOUR®, and Jack Nicklaus® for golf apparel. Additional information on the Company is available at  http://www.pery.com .

Safe Harbor Statement

We caution readers that the forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations rather than historical facts and they are indicated by words or phrases such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "proforma," "project," "seek," "should," "target," or "will" or the negative thereof or other variations thereon and similar words or phrases or comparable terminology. Such forward-looking statements include, but are not limited to, statements regarding Perry Ellis’ strategic operating review, growth initiatives and internal operating improvements intended to drive revenues and enhance profitability, the implementation of Perry Ellis’ profitability improvement plan and Perry Ellis’ plans to exit underperforming, low growth brands and businesses. We have based such forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements, many of which are beyond our control.  These factors include: general economic conditions, a significant decrease in business from or loss of any of our major customers or programs, anticipated and unanticipated trends and conditions in our industry, including the impact of recent or future retail and wholesale consolidation, recent and future economic conditions, including turmoil in the financial and credit markets, the effectiveness of our planned advertising, marketing and promotional campaigns, our ability to contain costs, disruptions in the supply chain, including, but not limited to these caused by port disruptions, our future capital needs and our ability to obtain financing, our ability to protect our trademarks, our ability to integrate acquired businesses, trademarks, trade names and licenses, our ability to predict consumer preferences and changes in fashion trends and consumer acceptance of both new designs and newly introduced products, the termination or non-renewal of any material license agreements to which we are a party, changes in the costs of raw materials, labor and advertising, our ability to carry out growth strategies including expansion in international and direct-to-consumer retail markets; the effectiveness of our plans, strategies, objectives, expectations and intentions which are subject to change at any time at our discretion, potential cyber risk and technology failures which could disrupt operations or result in a data breach, the level of consumer spending for apparel and other merchandise, our ability to compete, exposure to foreign currency risk and interest rate risk, the impact to our business resulting from the United Kingdom’s referendum vote to exit the European Union and the uncertainty surrounding the terms and conditions of such a withdrawal, as well as the related impact to global stock markets and currency exchange rates; possible disruption in commercial activities due to terrorist activity and armed conflict, actions of activist investors and the cost and disruption of responding to those actions, and other factors set forth in Perry Ellis' filings with the Securities and Exchange Commission. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties detailed in Perry Ellis' filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which are valid only as of the date they were made. We undertake no obligation to update or revise any forward-looking statements to reflect new information or the occurrence of unanticipated events or otherwise.

Contact: Allison Malkin, ICR 203-682-8225

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 527

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 116

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 350

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 63

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 554

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 356

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 270

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 462

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Top Large-Cap Stocks to Watch for Future Growth Opportunities

Updated Category News Views 409

Emerging Large-Cap Stocks: Evaluating Performance Last week proved to be a robust period for several large-cap stocks, demonstrating significant gains on the market. If you're looking to expand your portfolio with top performers, it's essential to keep an eye on these standout companies. AeroVironment's Spectacular Performance AeroVironment, Inc. (NASDAQ: AVAV) saw its...

Continue Reading
Celebrating 80 Years of Unity: Manchester Congress Reimagined

Updated Category News Views 373

Celebrating the Legacy of the Manchester Congress The Pan-African Progressive Front (PPF), working hand in hand with various organizations, has embarked on an exciting journey to commemorate the 80th anniversary of the historic Manchester Congress. This momentous event, pivotal in shaping pan-African unity and liberation movements, is set to stir conversations and inspire...

Continue Reading
Stifel Optimistic on Nurix's NX-5948 Ahead of ASH Presentation

Updated Category News Views 86

Stifel's Positive Adjustment for Nurix Therapeutics Stock Stifel, a well-known financial services firm, has shown renewed confidence in Nurix Therapeutics Inc. (NASDAQ: NRIX) by increasing its price target for the company’s shares from $30 to $34 while keeping a Buy rating. This optimistic outlook reflects anticipation surrounding Nurix's ongoing drug trials,...

Continue Reading
Josh Christie Steps Up as Chief Managing Partner at Ice Miller

Updated Category News Views 266

Josh Christie Steps Up as Chief Managing Partner at Ice Miller Ice Miller is excited to share that Joshua Christie will serve as its new Chief Managing Partner starting January 1, 2026. His election reflects the firm’s trust in his leadership capabilities and vision for the future. Based in the Indianapolis office, Christie has been an integral part of Ice Miller since...

Continue Reading
IPSEN's Latest Buy-Back Initiative: Weekly Summary Insights

Updated Category News Views 156

IPSEN's Buy-Back Program Overview IPSEN has embarked on an exciting buy-back program aimed at enhancing shareholder value by strategically purchasing its own shares. This initiative is not only an investment in its financial health but also reflects the confidence IPSEN has in its future. As of Week 33, 2025, a comprehensive overview of the transactions executed...

Continue Reading